[CLSTR]
< Back to situation

[REVISION HISTORY]

HPV vaccination research and global policy

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-10-14 11:22 UTC → 2026-10-15 03:18 UTC · added removed

A Swedish study published in the journal BMJ, analyzing approximately 625,000 first-time births between 2006 and 2023, suggests that HPV vaccination may reduce risks associated with pregnancy and childbirth. Researchers found that vaccinated women faced a 5% lower relative risk of preterm birth before the 37th week, with a 15% risk reduction for births occurring between the 28th and 31st weeks. Other observed benefits included lower risks of spontaneous preterm birth, premature rupture of membranes, and significant developmental delays in newborns. Researchers from the Karolinska Institutet and the University of Gothenburg noted that protective effects were particularly strong among women vaccinated before age 17. However, they cautioned that because the study is observational, it does not definitively prove the vaccine is the direct cause of these outcomes, as lifestyle or socioeconomic factors could be involved. Following these findings, In response to global coverage gaps, the World Health Organization (WHO) is evaluating a proposal to introduce routine HPV vaccinations for children aged 4 to 8. This initiative, presented by the and its Strategic Advisory Group of Experts (SAGE) on Immunization, seeks Immunization have issued new guidance to increase combat cervical cancer. With global vaccination coverage from 33% toward a 90% target. currently at 33%, SAGE experts noted experts, led by chair Anthony Scott, recommend that countries consider routine HPV vaccination for girls as young as four to eight years old to improve uptake. The committee affirmed that a single-dose vaccination schedule for girls aged 9 to 14 is remains the most effective strategy to reach this goal, following findings that a single dose provides comparable protection to a two-dose regimen for that age group. The WHO the 90% coverage goal. Regional implementation is also considering catch-up vaccinations advancing: Eswatini has launched a nationwide primary school campaign for women up nine-year-old girls, while Mexico has expanded its national strategy to age 25 or 30 include boys and other priority groups to improve accessibility prevent HPV-related cancers of the anus, penis, and combat cervical cancer. oropharynx.

Versions

  1. 2026-10-15 03:18 UTC HPV vaccination research and global policy
  2. 2026-10-14 11:22 UTC HPV vaccination research and global policy
  3. 2026-10-13 16:19 UTC HPV vaccination research and global policy

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.